Latest Breaking News On - Physicians education resource - Page 1 : comparemela.com

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

United statesEteläuomen läiSouth koreaJin wangGenentechf hoffmannAsher biotherapeuticsDaiichi sankyoChipscreen biosciencesBristol myers squibbAshfield medcommsMerck biopharmMerck seronoSamsung bioepisLyell immunopharmaCalithera biosciencesEli lilly

Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy

This open-label, single-group, phase 3 trial evaluates eplontersen, an investigational ligand-conjugated antisense oligonucleotide, in adults with hereditary am

Rio de janeiroEstado do rioUnited statesNew zealandCidade universitariaAlnylam pharmacauticalsMarques jrClementino fraga filhoWaddington cruzIonis astrazenecaRodolpho paulo roccoIntellia regeneronResearch to practiceAmerican academy of neurology annual meetingIonis pharmaceuticalsIonis pharmaceuticals inc

Six Action Steps to Address Global Disparities in Parkinson Disease

This Special Communication discusses findings from a World Health Organization consultation workshop on global disparities in Parkinson disease, including 6 wor

Switzerland generalUnited statesStanford universityUnited kingdomSouth africaWorld health organizationAl qahirahRobert roseParkinson verenigingSunovion pharmaMccarthy gruberDarm stichtingStichting woelse waardAlkemade keulsExcellus bluecross blueshieldGenentech roche

Selinexor maintenance extends PFS in endometrial cancer subgroup with high unmet need

Selinexor maintenance extends PFS in endometrial cancer subgroup with high unmet need
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesSelinexor xpovioAstellas pharmaIovance biotherapeuticsDiscussantgini flemingNuvation bioBrianm slomovitzBydevin mclaughlinMindy valcarcelUniversity of chicagoCaris life sciencesK group betaEli lilly coSyros pharmaceuticalsMount sinai medical centerKaryopharm therapeutics

Treating and Assessing Treatment Response: AL

Treating and Assessing Treatment Response: AL
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesMemorial sloan kettering cancer centerNew yorkIonis akceaMeghan macdonaldStephen casselliHeather tarboxPatrick hartyJennifer liuMoriea gertzGiovanni palladiniRoland seidler jrDaniel lenihanAccreditation council for continuing medical educationDrug administrationFrance foundation